[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Skin Microbiome Modulator Industry Research Report 2023

August 2023 | 93 pages | ID: S4D88F6EEB9DEN
APO Research

US$ 2,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Highlights

The global Skin Microbiome Modulator market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.

North American market for Skin Microbiome Modulator is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.

Asia-Pacific market for Skin Microbiome Modulator is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.

The major global companies of Skin Microbiome Modulator include L’Orйal S.A., Unilever, The Estйe Lauder Companies, Johnson & Johnson, Revlon, Evelo Biosciences, AOBiome, Azitra and GALLINЙE, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

The global market for Skin Microbiome Modulator in Skin Care is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Probiotics, which accounted for % of the global market of Skin Microbiome Modulator in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2024 to 2029.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Skin Microbiome Modulator, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Skin Microbiome Modulator.

The Skin Microbiome Modulator market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Skin Microbiome Modulator market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Skin Microbiome Modulator companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
  • L’Orйal S.A.
  • Unilever
  • The Estйe Lauder Companies
  • Johnson & Johnson
  • Revlon
  • Evelo Biosciences
  • AOBiome
  • Azitra
  • GALLINЙE
  • Glowbiotics
Product Type Insights

Global markets are presented by Skin Microbiome Modulator type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Skin Microbiome Modulator are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).

Skin Microbiome Modulator segment by Type
  • Probiotics
  • Prebiotics
  • Drugs
Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).

This report also outlines the market trends of each segment and consumer behaviors impacting the Skin Microbiome Modulator market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Skin Microbiome Modulator market.

Skin Microbiome Modulator Segment by Application
  • Skin Care
  • Hair Care
  • Others
Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA
Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Skin Microbiome Modulator market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Skin Microbiome Modulator market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Skin Microbiome Modulator and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Skin Microbiome Modulator industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Skin Microbiome Modulator.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Skin Microbiome Modulator companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.
1 PREFACE

1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
  1.5.1 Secondary Sources
  1.5.2 Primary Sources

2 MARKET OVERVIEW

2.1 Product Definition
2.2 Skin Microbiome Modulator by Type
  2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
  1.2.2 Probiotics
  1.2.3 Prebiotics
  1.2.4 Drugs
2.3 Skin Microbiome Modulator by Application
  2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
  2.3.2 Skin Care
  2.3.3 Hair Care
  2.3.4 Others
2.4 Assumptions and Limitations

3 SKIN MICROBIOME MODULATOR BREAKDOWN DATA BY TYPE

3.1 Global Skin Microbiome Modulator Historic Market Size by Type (2018-2023)
3.2 Global Skin Microbiome Modulator Forecasted Market Size by Type (2023-2028)

4 SKIN MICROBIOME MODULATOR BREAKDOWN DATA BY APPLICATION

4.1 Global Skin Microbiome Modulator Historic Market Size by Application (2018-2023)
4.2 Global Skin Microbiome Modulator Forecasted Market Size by Application (2018-2023)

5 GLOBAL GROWTH TRENDS

5.1 Global Skin Microbiome Modulator Market Perspective (2018-2029)
5.2 Global Skin Microbiome Modulator Growth Trends by Region
  5.2.1 Global Skin Microbiome Modulator Market Size by Region: 2018 VS 2022 VS 2029
  5.2.2 Skin Microbiome Modulator Historic Market Size by Region (2018-2023)
  5.2.3 Skin Microbiome Modulator Forecasted Market Size by Region (2024-2029)
5.3 Skin Microbiome Modulator Market Dynamics
  5.3.1 Skin Microbiome Modulator Industry Trends
  5.3.2 Skin Microbiome Modulator Market Drivers
  5.3.3 Skin Microbiome Modulator Market Challenges
  5.3.4 Skin Microbiome Modulator Market Restraints

6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS

6.1 Global Top Skin Microbiome Modulator Players by Revenue
  6.1.1 Global Top Skin Microbiome Modulator Players by Revenue (2018-2023)
  6.1.2 Global Skin Microbiome Modulator Revenue Market Share by Players (2018-2023)
6.2 Global Skin Microbiome Modulator Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Skin Microbiome Modulator Head office and Area Served
6.4 Global Skin Microbiome Modulator Players, Product Type & Application
6.5 Global Skin Microbiome Modulator Players, Date of Enter into This Industry
6.6 Global Skin Microbiome Modulator Market CR5 and HHI
6.7 Global Players Mergers & Acquisition

7 NORTH AMERICA

7.1 North America Skin Microbiome Modulator Market Size (2018-2029)
7.2 North America Skin Microbiome Modulator Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Skin Microbiome Modulator Market Size by Country (2018-2023)
7.4 North America Skin Microbiome Modulator Market Size by Country (2024-2029)
7.5 United States
7.6 Canada

8 EUROPE

8.1 Europe Skin Microbiome Modulator Market Size (2018-2029)
8.2 Europe Skin Microbiome Modulator Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Skin Microbiome Modulator Market Size by Country (2018-2023)
8.4 Europe Skin Microbiome Modulator Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries

9 ASIA-PACIFIC

9.1 Asia-Pacific Skin Microbiome Modulator Market Size (2018-2029)
9.2 Asia-Pacific Skin Microbiome Modulator Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Skin Microbiome Modulator Market Size by Country (2018-2023)
9.4 Asia-Pacific Skin Microbiome Modulator Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia

10 LATIN AMERICA

10.1 Latin America Skin Microbiome Modulator Market Size (2018-2029)
10.2 Latin America Skin Microbiome Modulator Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Skin Microbiome Modulator Market Size by Country (2018-2023)
10.4 Latin America Skin Microbiome Modulator Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Skin Microbiome Modulator Market Size (2018-2029)
11.2 Middle East & Africa Skin Microbiome Modulator Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Skin Microbiome Modulator Market Size by Country (2018-2023)
11.4 Middle East & Africa Skin Microbiome Modulator Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE

12 PLAYERS PROFILED

11.1 L’Orйal S.A.
  11.1.1 L’Orйal S.A. Company Detail
  11.1.2 L’Orйal S.A. Business Overview
  11.1.3 L’Orйal S.A. Skin Microbiome Modulator Introduction
  11.1.4 L’Orйal S.A. Revenue in Skin Microbiome Modulator Business (2017-2022)
  11.1.5 L’Orйal S.A. Recent Development
11.2 Unilever
  11.2.1 Unilever Company Detail
  11.2.2 Unilever Business Overview
  11.2.3 Unilever Skin Microbiome Modulator Introduction
  11.2.4 Unilever Revenue in Skin Microbiome Modulator Business (2017-2022)
  11.2.5 Unilever Recent Development
11.3 The Estйe Lauder Companies
  11.3.1 The Estйe Lauder Companies Company Detail
  11.3.2 The Estйe Lauder Companies Business Overview
  11.3.3 The Estйe Lauder Companies Skin Microbiome Modulator Introduction
  11.3.4 The Estйe Lauder Companies Revenue in Skin Microbiome Modulator Business (2017-2022)
  11.3.5 The Estйe Lauder Companies Recent Development
11.4 Johnson & Johnson
  11.4.1 Johnson & Johnson Company Detail
  11.4.2 Johnson & Johnson Business Overview
  11.4.3 Johnson & Johnson Skin Microbiome Modulator Introduction
  11.4.4 Johnson & Johnson Revenue in Skin Microbiome Modulator Business (2017-2022)
  11.4.5 Johnson & Johnson Recent Development
11.5 Revlon
  11.5.1 Revlon Company Detail
  11.5.2 Revlon Business Overview
  11.5.3 Revlon Skin Microbiome Modulator Introduction
  11.5.4 Revlon Revenue in Skin Microbiome Modulator Business (2017-2022)
  11.5.5 Revlon Recent Development
11.6 Evelo Biosciences
  11.6.1 Evelo Biosciences Company Detail
  11.6.2 Evelo Biosciences Business Overview
  11.6.3 Evelo Biosciences Skin Microbiome Modulator Introduction
  11.6.4 Evelo Biosciences Revenue in Skin Microbiome Modulator Business (2017-2022)
  11.6.5 Evelo Biosciences Recent Development
11.7 AOBiome
  11.7.1 AOBiome Company Detail
  11.7.2 AOBiome Business Overview
  11.7.3 AOBiome Skin Microbiome Modulator Introduction
  11.7.4 AOBiome Revenue in Skin Microbiome Modulator Business (2017-2022)
  11.7.5 AOBiome Recent Development
11.8 Azitra
  11.8.1 Azitra Company Detail
  11.8.2 Azitra Business Overview
  11.8.3 Azitra Skin Microbiome Modulator Introduction
  11.8.4 Azitra Revenue in Skin Microbiome Modulator Business (2017-2022)
  11.8.5 Azitra Recent Development
11.9 GALLINЙE
  11.9.1 GALLINЙE Company Detail
  11.9.2 GALLINЙE Business Overview
  11.9.3 GALLINЙE Skin Microbiome Modulator Introduction
  11.9.4 GALLINЙE Revenue in Skin Microbiome Modulator Business (2017-2022)
  11.9.5 GALLINЙE Recent Development
11.10 Glowbiotics
  11.10.1 Glowbiotics Company Detail
  11.10.2 Glowbiotics Business Overview
  11.10.3 Glowbiotics Skin Microbiome Modulator Introduction
  11.10.4 Glowbiotics Revenue in Skin Microbiome Modulator Business (2017-2022)
  11.10.5 Glowbiotics Recent Development

13 REPORT CONCLUSION


14 DISCLAIMER


LIST OF TABLES

Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Skin Microbiome Modulator Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Skin Microbiome Modulator Revenue Market Share by Type (2018-2023)
Table 7. Global Skin Microbiome Modulator Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Skin Microbiome Modulator Revenue Market Share by Type (2024-2029)
Table 9. Global Skin Microbiome Modulator Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Skin Microbiome Modulator Revenue Market Share by Application (2018-2023)
Table 11. Global Skin Microbiome Modulator Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Skin Microbiome Modulator Revenue Market Share by Application (2024-2029)
Table 13. Global Skin Microbiome Modulator Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Skin Microbiome Modulator Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Skin Microbiome Modulator Market Share by Region (2018-2023)
Table 16. Global Skin Microbiome Modulator Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Skin Microbiome Modulator Market Share by Region (2024-2029)
Table 18. Skin Microbiome Modulator Market Trends
Table 19. Skin Microbiome Modulator Market Drivers
Table 20. Skin Microbiome Modulator Market Challenges
Table 21. Skin Microbiome Modulator Market Restraints
Table 22. Global Top Skin Microbiome Modulator Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Skin Microbiome Modulator Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Skin Microbiome Modulator Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Skin Microbiome Modulator, Headquarters and Area Served
Table 26. Global Skin Microbiome Modulator Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Skin Microbiome Modulator by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Skin Microbiome Modulator Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Skin Microbiome Modulator Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Skin Microbiome Modulator Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Skin Microbiome Modulator Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Skin Microbiome Modulator Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Skin Microbiome Modulator Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Skin Microbiome Modulator Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Skin Microbiome Modulator Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Skin Microbiome Modulator Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Skin Microbiome Modulator Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Skin Microbiome Modulator Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Skin Microbiome Modulator Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Skin Microbiome Modulator Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Skin Microbiome Modulator Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Skin Microbiome Modulator Market Size by Country (2024-2029) & (US$ Million)
Table 45. L’Orйal S.A. Company Detail
Table 46. L’Orйal S.A. Business Overview
Table 47. L’Orйal S.A. Skin Microbiome Modulator Product
Table 48. L’Orйal S.A. Revenue in Skin Microbiome Modulator Business (2017-2022) & (US$ Million)
Table 49. L’Orйal S.A. Recent Development
Table 50. Unilever Company Detail
Table 51. Unilever Business Overview
Table 52. Unilever Skin Microbiome Modulator Product
Table 53. Unilever Revenue in Skin Microbiome Modulator Business (2017-2022) & (US$ Million)
Table 54. Unilever Recent Development
Table 55. The Estйe Lauder Companies Company Detail
Table 56. The Estйe Lauder Companies Business Overview
Table 57. The Estйe Lauder Companies Skin Microbiome Modulator Product
Table 58. The Estйe Lauder Companies Revenue in Skin Microbiome Modulator Business (2017-2022) & (US$ Million)
Table 59. The Estйe Lauder Companies Recent Development
Table 60. Johnson & Johnson Company Detail
Table 61. Johnson & Johnson Business Overview
Table 62. Johnson & Johnson Skin Microbiome Modulator Product
Table 63. Johnson & Johnson Revenue in Skin Microbiome Modulator Business (2017-2022) & (US$ Million)
Table 64. Johnson & Johnson Recent Development
Table 65. Revlon Company Detail
Table 66. Revlon Business Overview
Table 67. Revlon Skin Microbiome Modulator Product
Table 68. Revlon Revenue in Skin Microbiome Modulator Business (2017-2022) & (US$ Million)
Table 69. Revlon Recent Development
Table 70. Evelo Biosciences Company Detail
Table 71. Evelo Biosciences Business Overview
Table 72. Evelo Biosciences Skin Microbiome Modulator Product
Table 73. Evelo Biosciences Revenue in Skin Microbiome Modulator Business (2017-2022) & (US$ Million)
Table 74. Evelo Biosciences Recent Development
Table 75. AOBiome Company Detail
Table 76. AOBiome Business Overview
Table 77. AOBiome Skin Microbiome Modulator Product
Table 78. AOBiome Revenue in Skin Microbiome Modulator Business (2017-2022) & (US$ Million)
Table 79. AOBiome Recent Development
Table 80. Azitra Company Detail
Table 81. Azitra Business Overview
Table 82. Azitra Skin Microbiome Modulator Product
Table 83. Azitra Revenue in Skin Microbiome Modulator Business (2017-2022) & (US$ Million)
Table 84. Azitra Recent Development
Table 85. GALLINЙE Company Detail
Table 86. GALLINЙE Business Overview
Table 87. GALLINЙE Skin Microbiome Modulator Product
Table 88. GALLINЙE Revenue in Skin Microbiome Modulator Business (2017-2022) & (US$ Million)
Table 89. GALLINЙE Recent Development
Table 90. Glowbiotics Company Detail
Table 91. Glowbiotics Business Overview
Table 92. Glowbiotics Skin Microbiome Modulator Product
Table 93. Glowbiotics Revenue in Skin Microbiome Modulator Business (2017-2022) & (US$ Million)
Table 94. Glowbiotics Recent Development
Table 95. L’Orйal S.A. Company Information
Table 96. L’Orйal S.A. Business Overview
Table 97. L’Orйal S.A. Skin Microbiome Modulator Revenue in Skin Microbiome Modulator Business (2018-2023) & (US$ Million)
Table 98. L’Orйal S.A. Revenue in Skin Microbiome Modulator Business (2018-2023) & (US$ Million) Portfolio
Table 99. L’Orйal S.A. Recent Development
Table 100. Unilever Company Information
Table 101. Unilever Business Overview
Table 102. Unilever Skin Microbiome Modulator Revenue in Skin Microbiome Modulator Business (2018-2023) & (US$ Million)
Table 103. Unilever Revenue in Skin Microbiome Modulator Business (2018-2023) & (US$ Million) Portfolio
Table 104. Unilever Recent Development
Table 105. The Estйe Lauder Companies Company Information
Table 106. The Estйe Lauder Companies Business Overview
Table 107. The Estйe Lauder Companies Skin Microbiome Modulator Revenue in Skin Microbiome Modulator Business (2018-2023) & (US$ Million)
Table 108. The Estйe Lauder Companies Revenue in Skin Microbiome Modulator Business (2018-2023) & (US$ Million) Portfolio
Table 109. The Estйe Lauder Companies Recent Development
Table 110. Johnson & Johnson Company Information
Table 111. Johnson & Johnson Business Overview
Table 112. Johnson & Johnson Skin Microbiome Modulator Revenue in Skin Microbiome Modulator Business (2018-2023) & (US$ Million)
Table 113. Johnson & Johnson Revenue in Skin Microbiome Modulator Business (2018-2023) & (US$ Million) Portfolio
Table 114. Johnson & Johnson Recent Development
Table 115. Revlon Company Information
Table 116. Revlon Business Overview
Table 117. Revlon Skin Microbiome Modulator Revenue in Skin Microbiome Modulator Business (2018-2023) & (US$ Million)
Table 118. Revlon Revenue in Skin Microbiome Modulator Business (2018-2023) & (US$ Million) Portfolio
Table 119. Revlon Recent Development
Table 120. Evelo Biosciences Company Information
Table 121. Evelo Biosciences Business Overview
Table 122. Evelo Biosciences Skin Microbiome Modulator Revenue in Skin Microbiome Modulator Business (2018-2023) & (US$ Million)
Table 123. Evelo Biosciences Revenue in Skin Microbiome Modulator Business (2018-2023) & (US$ Million) Portfolio
Table 124. Evelo Biosciences Recent Development
Table 125. AOBiome Company Information
Table 126. AOBiome Business Overview
Table 127. AOBiome Skin Microbiome Modulator Revenue in Skin Microbiome Modulator Business (2018-2023) & (US$ Million)
Table 128. AOBiome Revenue in Skin Microbiome Modulator Business (2018-2023) & (US$ Million) Portfolio
Table 129. AOBiome Recent Development
Table 130. Azitra Company Information
Table 131. Azitra Business Overview
Table 132. Azitra Skin Microbiome Modulator Revenue in Skin Microbiome Modulator Business (2018-2023) & (US$ Million)
Table 133. Azitra Revenue in Skin Microbiome Modulator Business (2018-2023) & (US$ Million) Portfolio
Table 134. Azitra Recent Development
Table 135. GALLINЙE Company Information
Table 136. GALLINЙE Business Overview
Table 137. GALLINЙE Skin Microbiome Modulator Revenue in Skin Microbiome Modulator Business (2018-2023) & (US$ Million)
Table 138. GALLINЙE Revenue in Skin Microbiome Modulator Business (2018-2023) & (US$ Million) Portfolio
Table 139. GALLINЙE Recent Development
Table 140. Glowbiotics Company Information
Table 141. Glowbiotics Business Overview
Table 142. Glowbiotics Skin Microbiome Modulator Revenue in Skin Microbiome Modulator Business (2018-2023) & (US$ Million)
Table 143. Glowbiotics Revenue in Skin Microbiome Modulator Business (2018-2023) & (US$ Million) Portfolio


More Publications